Keep updated with the latest MDPP news via our newsletter.
Congratulations to South Australian company AusHealth Research on their recent commercial success with their Vial Hugger product.
AusHealth (previously Medvet Science) approached the MDPP in late 2017 with their product, a medical accessory invented by South Australian ophthalmologist Weng-Onn Chan at the Royal Adelaide Hospital. The Vial Hugger device conveniently and securely holds vials into place, to reduce the risk of needle stick injury.
Whilst the product did not meet the MDPP criteria for a full project, the MDPP were able to assist the company with introductions to local manufacturers and provide feedback on their product.
Mr Greg Johansen, MD & CEO at AusHealth, said these introductions were extremely valuable.
“We took on board the feedback that the MDPP provided when commercialising this product and have now received two initial orders from Bayer and Inservio, with more orders expected in the near future” said Mr Johansen.
“The MDPP were able to connect us to the right expertise, which allowed us to get off to the best start”.
If you would like to learn more about the Vial Hugger, visit the AusHealth website.
18 February 2019
The Medical Device Partnering Program (led by Flinders University) has welcomed the Federal Government’s announcement today that the Program’s partnership with MTPConnect, BioCurate and UniQuest will operate the $22.3 million Biomedical Translation Bridge (BTB) Program.
The BTB program forms part of the Federal Government’s Medical Research Future Fund and aims to help early stage health and medical research ventures reach proof-of-concept stage.
MDPP Director Professor Karen Reynolds said today’s announcement acknowledges the reputation of the Program and cements the MDPPs role as connector within the medtech sector.
"MDPP has a 10-year track record of successfully facilitating early-stage ideation and research for new medical devices. Through the BTB program we will leverage our diverse connections and expertise to optimise the success of Australia's medtech ventures," Professor Reynolds said.
Through the BTB partnership, the MDPP will assess and support eligible medical technology applications for funding, whilst BioCurate and UniQuest will together do the same for therapeutics.
MTPConnect, the Medical Technologies and Pharmaceuticals Industry Growth Centre, will administer the BTB Program.
MTPConnect CEO Dr Dan Grant said the partners bring decades of industry-based experience and an enviable track record in research translation to the program.
"By joining forces with BioCurate, UniQuest and MDPP we've created a powerful partnership venture that brings national reach, industry capabilities and expertise and commercial know-how to the task of boosting translation of Australia's healthtech research," Dr Grant said.
"Under the Biomedical Translation Bridge (BTB) program, projects for new therapies, technologies and medical devices will be eligible for up to $1 million over a period of up to three years to support translation of Australian medical research through to the proof of concept stage.
"The BTB program has a strong commercial imperative, driving development of research initiatives to improve the health of Australians that also generate commercial returns to help create the high paying jobs of the future."
"MTPConnect will also partner with the Bridge and BridgeTech programs from the Queensland University of Technology to provide opportunities for skills development to applicants, further enhancing the commercialisation advice and nurturing we can provide to BTB applicants."
Read the full MTPConnect media release here.
The Medical Device Partnering Program (MDPP) is an ideas incubator - fostering collaborations between researchers, industry, end-users and government to develop medical technologies with global market potential.
MDPP is unique in its focus and the way that it operates. It works at the very early stage, turning ideas into proven concepts. It has reliable processes and tools that enable partners to rapidly work together under low risk conditions. It is able to leverage a diverse range of expertise to contribute to product conceptualisation, including health professionals, manufacturers, engineers and service providers. The focused scale of a 250-hour project, combined with a product opportunity assessment, delivers tangible outcomes for clients.
Visit www.mdpp.org.au for more information.
The Medical Device Partnering Program (MDPP) is excited to welcome the newest members of the MDPP team, based in our new Victorian office.
Thanks to support from LaunchVic, the state government agency charged with growing the Victorian startup ecosystem, the MDPP has expanded into Victoria, with the new team based at Hawthorn.
Led by Swinburne University of Technology, the Victorian MDPP partnership brings together CSIRO, The University of Melbourne, Monash University, RMIT University, Australian National Fabrication Facility (ANFF) and BioMedical Research Victoria. It leverages the proven model and processes developed and implemented by Flinders University across 10 years.
Regional Director of the MDPP in Victoria, Professor Sally McArthur, is thrilled about the announcement of her new team.
“We have attracted some great talent to the team, each member bringing experience and knowledge that will enable us to support and build the medtech sector in Victoria”, says Professor McArthur.
“Victoria already has excellent research expertise and an entrepreneurial clinical community. With the new MDPP team now on board in Victoria, we are equipped to work together with our partners and wider network to connect stakeholders, untap ideas and rapidly progress new product opportunities in the Victorian medtech sector”.
National MDPP Director and Founder, Professor Karen Reynolds, says this significant milestone will allow the MDPP to make even more impact across Australia.
“The MDPP has been operating in South Australia for over 10 years, and over this time, has developed a proven model with outstanding results for the medtech industry. With the addition of the team in Victoria, we now have people ‘on the ground’ to benefit the State and sector in Australia more broadly”, says Professor Reynolds.
The national expansion of the MDPP has been supported by MTPConnect and the Growth Centres Initiative.
The MDPP Victoria team includes:
The MDPP will officially launch the Victorian node with an event to be held in the coming months.
Learn more about the team here.
Our lead Victorian partner, Swinburne University are currently recruiting for:
Dont miss this great opportunity to join the MDPP in Victoria.
The closing date is 5 November.
Announced this morning by MTPConnect CEO Dr Dan Grant, the Medical Device Partnering Program is one of three key life sciences projects to have been awarded new funding.
The funding from MTPConnect, the Medical Technologies and Pharmaceuticals Industry Growth Centre, will enable the MDPP to continue our ambitious pledge to expand the MDPP nationally.
Professor Karen Reynolds, Director of the Medical Device Partnering Program (MDPP) says her ambition has always been to create a national program.
“This new funding from MTPConnect will allow us to build on our successes in South Australia and pursue the expansion of the MDPP on a national scale," Professor Reynolds explained.
"The support will allow us to formalise partnerships, establish a comprehensive national capability directory and create extensive training materials, with the aim to commence operations of a national MDPP in 2019.”
South Australian start-up Prohab will launch its new rehabilitation device at the Gold Coast 2018 Commonwealth Games this month.
The Prohab rehab device connects to standard resistance bands or cables, widely used in physiotherapy, to precisely measure the force applied to the band.
The data is then captured and sent to an app where it can be visualised instantaneously as well as tracked over time.
An Adelaide invention that communicates rehabilitation improvements in real time, helping patients stay on track with treatment, is ready for trial and primed for export.
The device is one of the latest projects to receive support from the State Government’s Medical Technologies Program, delivered through Flinders University’s innovative Medical Device Partnering Program (MDPP).